Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$43.6M |
| 2 |
Johnson Controls International
JCI
|
+$41.3M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$35.6M |
| 4 |
Telus
TU
|
+$34.2M |
| 5 |
Dell
DELL
|
+$30M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 2 |
Annaly Capital Management
NLY
|
+$81.7M |
| 3 |
Thomson Reuters
TRI
|
+$78.4M |
| 4 |
AGNC Investment
AGNC
|
+$53.4M |
| 5 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$50.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.52% |
| 2 | Healthcare | 14.8% |
| 3 | Consumer Discretionary | 10.63% |
| 4 | Communication Services | 10.15% |
| 5 | Consumer Staples | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LTXB
1426
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $2.25M | ﹤0.01% |
71,000
-2,700
| -4% | -$79.9K |
|
1427
Independent Bank
INDB
$4.05B
| $2.25M | ﹤0.01% |
41,500
-1,600
| -4% | -$81.5K |
|
1428
8x8 Inc
EGHT
$290M
| $2.24M | ﹤0.01% |
145,100
-5,900
| -4% | -$83.9K |
|
1429
HUB Group
HUBG
$2.46B
| $2.23M | ﹤0.01% |
109,600
-6,800
| -6% | -$138K |
|
1430
Quaker Houghton
KWR
$2.95B
| $2.23M | ﹤0.01% |
21,000
-800
| -4% | -$78.1K |
|
|
OCLR
1431
DELISTED
Oclaro Inc.
OCLR
| $2.23M | ﹤0.01% |
260,200
+85,800
| +49% | +$597K |
|
1432
Enerpac Tool Group
EPAC
$1.91B
| $2.22M | ﹤0.01% |
95,700
-3,600
| -4% | -$84.3K |
|
1433
HEICO Corp
HEI
$52.1B
| $2.22M | ﹤0.01% |
78,308
-2,442
| -3% | -$69K |
|
1434
Renasant Corp
RNST
$4B
| $2.22M | ﹤0.01% |
66,000
+1,900
| +3% | +$63.8K |
|
|
SCTY
1435
DELISTED
SolarCity Corporation
SCTY
| $2.22M | ﹤0.01% |
113,500
+7,900
| +7% | +$177K |
|
1436
NBT Bancorp
NBTB
$2.78B
| $2.22M | ﹤0.01% |
67,500
-500
| -0.7% | -$15.5K |
|
1437
Omnicell
OMCL
$1.69B
| $2.21M | ﹤0.01% |
57,700
-2,100
| -4% | -$78.3K |
|
1438
Global Net Lease
GNL
$1.9B
| $2.2M | ﹤0.01% |
89,967
-2,934
| -3% | -$73.5K |
|
|
CSGS
1439
DELISTED
CSG Systems International
CSGS
| $2.2M | ﹤0.01% |
53,200
-2,100
| -4% | -$88K |
|
|
SYNT
1440
DELISTED
Syntel Inc
SYNT
| $2.2M | ﹤0.01% |
52,400
-1,700
| -3% | -$76.1K |
|
|
ONCE
1441
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $2.19M | ﹤0.01% |
36,500
-100
| -0.3% | -$5.76K |
|
1442
Coherent
COHR
$64B
| $2.19M | ﹤0.01% |
89,900
-2,900
| -3% | -$61.3K |
|
1443
Fabrinet
FN
$20.5B
| $2.19M | ﹤0.01% |
49,040
-1,200
| -2% | -$47.6K |
|
|
SCAI
1444
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $2.18M | ﹤0.01% |
44,800
-1,000
| -2% | -$46.1K |
|
|
NP
1445
DELISTED
Neenah, Inc. Common Stock
NP
| $2.18M | ﹤0.01% |
27,600
-1,100
| -4% | -$84.4K |
|
1446
Celestica
CLS
$43.8B
| $2.18M | ﹤0.01% |
201,500
-10,000
| -5% | -$105K |
|
1447
Halozyme
HALO
$11.6B
| $2.18M | ﹤0.01% |
180,500
-4,500
| -2% | -$46K |
|
|
CVSA
1448
Covista Inc
CVSA
$4.36B
| $2.18M | ﹤0.01% |
94,400
-2,900
| -3% | -$64.7K |
|
|
SVU
1449
DELISTED
SUPERVALU Inc.
SVU
| $2.17M | ﹤0.01% |
62,271
-2,372
| -4% | -$83.9K |
|
1450
Dillards
DDS
$9.93B
| $2.17M | ﹤0.01% |
34,500
-2,200
| -6% | -$138K |
|
Similar funds
Swiss National Bank's Q3 2016 Portfolio in Review
As of Q3 2016, Swiss National Bank held 2,590 positions worth $62.4B, up 0.99% from $61.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q3 2016: portfolio turnover was 2.4%. Swiss National Bank opened 9 new positions and exited 54, leaving the 2,590-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q3 2016 buy was Fortive: 1,359,115 shares worth $43.6M.
- Swiss National Bank added most to Johnson Controls International in Q3 2016, an estimated $41.3M increase.
- Swiss National Bank's biggest Q3 2016 reduction was Danaher, cutting an estimated $45.6M.
- Swiss National Bank fully exited EMC CORPORATION in Q3 2016, selling an estimated $170M.
- Swiss National Bank's ten largest holdings make up 16% of its $62.4B portfolio in Q3 2016.
- Swiss National Bank opened 9 new positions and closed 54 in Q3 2016.
- Swiss National Bank's portfolio value rose 0.99% quarter-over-quarter to $62.4B.
Based on Swiss National Bank's 13F filing for Q3 2016, filed 7 Nov 2016.